Overview

This trial is active, not recruiting.

Conditions atrial fibrillation, atrial flutter
Sponsor The Cleveland Clinic
Collaborator Alive Cor
Start date August 2014
End date August 2014
Trial size 60 participants
Trial identifier NCT02214069, 14-612

Summary

The purpose of this study is to examine whether patients can use the AliveCor case to record their heart rhythm and whether they can interpret the recordings on their own. AliveCor is a new monitoring technology used with a smart phone which allows patients to record their rhythm. The investigators goal is to assess if patients can use the AliveCor to record their rhythm, interpret the rhythm results to assess whether they are in sinus rhythm (normal rhythm) or atrial fibrillation/flutter.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Measure
Examine whether patients can use the AliveCor case to record their rhythm and whether they can interpret the recordings on their own.
time frame: 6 month

Secondary Outcomes

Measure
Assess the correlation between QT interval derived from the AliveCor device compared to standard 12 lead ECG, as assessed by the overreading electrophysiologists.
time frame: 6 montha

Eligibility Criteria

Male or female participants from 18 years up to 80 years old.

Inclusion Criteria: 1. Male or female between > 18 and < 80 years of age 2. Paroxysmal or persistent atrial fibrillation 3. Admitted for antiarrhythmic drug loading (Dofetilide or Sotalol) 4. Already has iPhone 4, 4S or 5 with data plan that accommodates the AliveCor case 5. Willing to use the Alive Cor case 6. Written informed consent Exclusion Criteria: 1. Unable or unwilling to use the Alive Cor case for their smart phone 2. Presence of a permanent pacemaker

Trial information was received from ClinicalTrials.gov and was last updated in August 2014.
Information provided to ClinicalTrials.gov by The Cleveland Clinic.